Risk assessment: Seasonal influenza 2011–2012 in Europe (EU/EEA countries)
ECDC produces an annual risk assessment for the seasonal influenza epidemics in Europe. This is following both a recommendation in the report on the handling of the 2009 pandemic adopted by the World Health Assembly in May 2011 and the model developed by ECDC during that pandemic. The first EU seasonal influenza risk assessment was published in January 2011, following the start of the influenza season in late November 2010. In 2012, the season started later than in most years, with the first five countries exceeding their epidemic threshold in week 3/2012.
Risk assessment: Seasonal influenza 2013–2014 in the EU/EEA countries
This document is a routine and planned risk assessment of the 2013-2014 seasonal influenza in EU/EEA countries. Active circulation of influenza has started late in Europe in the 2013-2014 season, with a different timing across EU/EEA countries, states the annual ECDC risk assessment on seasonal influenza.
Risk assessment: Seasonal influenza 2014–2015 in the EU/EEA countries
This risk assessment covers the 2014–2015 influenza season in the European Union and European Economic Area (EU/EEA).
Risk assessment: Seasonal influenza 2012/13 in Europe (EU/EEA countries)
ECDC has produced an annual risk assessment of the seasonal influenza epidemics in Europe since the 2010/11 season following the model developed by ECDC during the 2009 pandemic. It gives an early description of the influenza season in the countries affected earliest, providing guidance and information to countries that are affected later, as influenza progresses across Europe over several months. It describes any specifics of the season, particularly in areas where public health or clinical actions are envisaged, as well as highlights areas of uncertainty where further work is required.
Risk assessment update: seasonal influenza, EU/EEA, 2016–2017
This updated risk assessment provides an overview of the current influenza situation in Europe.
Rapid risk assessment: Influenza-associated invasive pulmonary aspergillosis, Europe
This report assesses the risk of invasive pulmonary aspergillosis (IPA) among patients with severe influenza in hospital intensive care units in the European Union (EU)/European Economic Area (EEA)
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Risk assessment: Swine-origin triple reassortant influenza A(H3N2) variant viruses in North America
Following recent increased reporting of human infections in the US with an influenza A(H3N2) variant virus of swine origin (A(H3N2)v), ECDC has updated its risk assessment. It concludes that the swine-origin influenza A(H3N2)v viruses do not currently pose a serious risk to human health in general and Europe in particular.
ECDC rapid risk assessment: Human cases of swine influenza without apparent exposure to pigs, United States and Mexico
On April 21, the United States reported on the existence of 2 human cases of swine influenza A (H1N1) infection. On 23 April, through intensified surveillance efforts, a total of 7 confirmed human cases of swine influenza A (H1N1) infection, were reported.
Rapid risk assessment on influenza A(H7N9) China, 12 April 2013
On 31 March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus isolated from three unlinked cases of severe respiratory disease in eastern China. This is the first time that human infection with avian influenza virus A(H7N9) has been identified.
Since then, human cases have continued to be reported from eastern China. As of 11 April, there were 38 laboratory-confirmed cases including ten deaths reported from four bordering provinces with a concentration of cases in and around Shanghai. Cases occur sporadically, without obvious epidemiological links. There is currently no confirmed human-to-human transmission.